cyclosporine has been researched along with End Stage Liver Disease in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (93.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Beetz, O; DeTemple, DE; Falk, CS; Kleine, M; Oldhafer, F; Timrott, K; Vondran, FWR; Wittauer, EM | 1 |
| Cai, Q; Chen, C; Chen, J; Huang, X; Jiang, Y; Ke, R; Liu, J; Xu, F; Yang, F | 1 |
| Denecke, T; Eurich, D; Neuhaus, P; Neuhaus, R; Oellinger, R; Pascher, A; Pratschke, J; Rademacher, S; Schoening, W; Schott, E; Seehofer, D; Sinn, M | 1 |
| Barg-Hock, H; Beneke, J; Ding, X; Jäckel, E; Klempnauer, J; Lanfermann, H; Pflugrad, H; Schrader, AK; Schrem, H; Tryc, AB; Weissenborn, K | 1 |
| Albhaisi, S; Arshad, T; Bhati, C; Driscoll, C; Lee, E; Patel, S; Reichman, T; Siddiqui, MB; Siddiqui, MS; Wolver, S | 1 |
| Grönroos, L; Helenius-Hietala, J; Isoniemi, H; Meurman, JH; Rissanen, H; Ruokonen, H; Suominen, L; Vehkalahti, MM | 1 |
| Czock, D; Eisenbach, C; Giese, T; Gotthardt, D; Roos, K; Schnitzler, P; Stremmel, W | 1 |
| Fukuhara, T; Ikegami, T; Itoh, S; Kato, M; Maehara, Y; Matsuura, Y; Nakamura, S; Shirabe, K; Yamamoto, S; Yoshizumi, T | 1 |
| Foroncewicz, B; Krawczyk, M; Lerut, J; Majewski, S; Mucha, K; Pączek, L | 1 |
| Coss, E; Dierkhising, R; Fan, C; Fussner, LA; Heimbach, JK; Leise, MD; Watt, KD | 1 |
| Adamczak, M; Dudzicz, S; Gazda, M; Gojowy, D; Karkoszka, H; Wiecek, A | 1 |
| Cuervas-Mons, V; D'Avola, D; Fábrega, E; Fraga, E; Gómez, MA; Herrero, JI; Jimenez, C; Lladó, L; Lopez, P; Martí, J; Ortiz de Urbina, J; Otero, E; Rios, A; Rodrigo, JM; Serrano, MT; Suarez, F | 1 |
| Fukuda, A; Hirata, Y; Kasahara, M; Kitajima, T; Narumoto, S; Sakamoto, S; Sasaki, K; Shigeta, T; Uchida, H | 1 |
| Ballarin, R; Cautero, N; Cocchi, S; Codeluppi, M; D'Amico, G; De Ruvo, N; Di Benedetto, F; Gerunda, GE; Guaraldi, G; Guerrini, GP; Iemmolo, RM; Mimmo, A; Montalti, R; Rompianesi, G; Serra, V; Smerieri, N; Spaggiari, M; Tarantino, G | 1 |
| Bahra, M; Boas-Knoop, S; Eurich, D; Kiessling, A; Neuhaus, P; Neuhaus, R; Neumann, UP; Puhl, G; Trautwein, C; Wasmuth, H; Yahyazadeh, A | 1 |
1 review(s) available for cyclosporine and End Stage Liver Disease
| Article | Year |
|---|---|
Risk factors for recurrent autoimmune liver diseases after liver transplantation: A meta-analysis.
Topics: Adult; Calcineurin Inhibitors; Cholangiocarcinoma; Cholangitis, Sclerosing; Colectomy; Cyclosporine; End Stage Liver Disease; Enzyme Inhibitors; Female; Graft Rejection; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Diseases; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Tacrolimus | 2020 |
14 other study(ies) available for cyclosporine and End Stage Liver Disease
| Article | Year |
|---|---|
Alloresponses of Mixed Lymphocyte Hepatocyte Culture to Immunosuppressive Drugs as an In-Vitro Model of Hepatocyte Transplantation.
Topics: Abatacept; Cell Transplantation; Coculture Techniques; Cyclosporine; End Stage Liver Disease; Everolimus; Hepatocytes; Humans; Immunosuppressive Agents; Lymphocytes | 2019 |
The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients.
Topics: Adult; Age Factors; Aged; Cyclosporine; End Stage Liver Disease; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kaplan-Meier Estimate; Liver Transplantation; Male; Middle Aged; Neoplasms; Prognosis; Proportional Hazards Models; Prospective Studies; Risk Factors; Smoking; Tacrolimus; Young Adult | 2017 |
Longterm calcineurin inhibitor therapy and brain function in patients after liver transplantation.
Topics: Aged; Brain; Calcineurin Inhibitors; Cognitive Dysfunction; Cyclosporine; End Stage Liver Disease; Female; Graft Rejection; Humans; Immunosuppression Therapy; Liver Transplantation; Magnetic Resonance Imaging; Male; Middle Aged; Tacrolimus; Time Factors | 2018 |
The Relationship Between Hypoadiponectinemia and Cardiovascular Events in Liver Transplant Recipients.
Topics: Adiponectin; Aged; Cardiovascular Diseases; Cyclosporine; Diabetes Complications; Dyslipidemias; End Stage Liver Disease; Female; Humans; Immunosuppression Therapy; Insulin Resistance; Liver Transplantation; Male; Metabolism, Inborn Errors; Middle Aged; Obesity; Proportional Hazards Models; Prospective Studies; Risk Assessment; Tacrolimus; Transplant Recipients; Treatment Outcome | 2019 |
Oral mucosal health in liver transplant recipients and controls.
Topics: Adult; Aged; Calcium Channel Blockers; Case-Control Studies; Cross-Sectional Studies; Cyclosporine; End Stage Liver Disease; Female; Gingival Diseases; Humans; Immunosuppressive Agents; Leukoplakia; Lichen Planus; Liver Failure, Acute; Liver Transplantation; Logistic Models; Male; Middle Aged; Mouth Mucosa; Oral Ulcer; Prevalence; Risk Factors; Tacrolimus | 2014 |
Pharmacodynamic monitoring of immunosuppressive effects indicates reduced cyclosporine activity during telaprevir therapy.
Topics: Antiviral Agents; Biomarkers; Cyclosporine; Dose-Response Relationship, Immunologic; Drug Interactions; Drug Monitoring; End Stage Liver Disease; Female; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Liver Transplantation; Male; Middle Aged; Oligopeptides; Predictive Value of Tests; Recurrence; Retrospective Studies; RNA, Messenger; RNA, Viral; Time Factors; Treatment Outcome; Viral Load | 2014 |
Reduced-dose telaprevir-based triple antiviral therapy for recurrent hepatitis C after living donor liver transplantation.
Topics: Aged; Anemia; Antiviral Agents; Cohort Studies; Cyclosporine; End Stage Liver Disease; Female; Glomerular Filtration Rate; Haplotypes; Hemoglobins; Hepacivirus; Hepatitis C, Chronic; High-Throughput Nucleotide Sequencing; Humans; Japan; Liver Transplantation; Living Donors; Male; Middle Aged; Mutation; Oligopeptides; Recurrence; RNA, Viral; Treatment Outcome | 2014 |
Cyclosporine is superior to tacrolimus in liver transplant recipients with recurrent psoriasis.
Topics: Adult; Cyclosporine; End Stage Liver Disease; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Psoriasis; Recurrence; Risk Factors; Tacrolimus; Transplant Recipients; Treatment Outcome | 2014 |
Cardiovascular disease after liver transplantation: When, What, and Who Is at Risk.
Topics: Adult; Biomarkers; Body Mass Index; Cardiovascular Diseases; Comorbidity; Cyclosporine; Diabetes Complications; End Stage Liver Disease; Female; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppression Therapy; Incidence; Liver Transplantation; Male; Metabolic Syndrome; Middle Aged; Obesity; Odds Ratio; Prevalence; Proportional Hazards Models; Retrospective Studies; Risk Factors; Tacrolimus | 2015 |
High Frequency of Arterial Hypertension in Patients After Liver Transplantation.
Topics: Adult; Blood Pressure; Calcineurin Inhibitors; Cyclosporine; End Stage Liver Disease; Everolimus; Female; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Tacrolimus | 2016 |
Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil.
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Cyclosporine; Diabetes Mellitus, Type 1; Dyslipidemias; End Stage Liver Disease; Female; Follow-Up Studies; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Liver Transplantation; Male; Metabolic Syndrome; Middle Aged; Mycophenolic Acid; Postoperative Complications; Prevalence; Prospective Studies; Risk Factors; Severity of Illness Index; Spain; Survival Analysis; Tacrolimus; Transplant Recipients | 2017 |
Living donor liver transplantation during the first 3 months of life.
Topics: Age Factors; Cyclosporine; Cytomegalovirus Infections; End Stage Liver Disease; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Infant; Infant, Newborn; Japan; Liver Failure, Acute; Liver Transplantation; Living Donors; Male; Retrospective Studies; Severity of Illness Index; Survival Rate; Tacrolimus | 2017 |
University of Modena experience in HIV-positive patients undergoing liver transplantation.
Topics: Adult; Antiretroviral Therapy, Highly Active; Carcinoma, Hepatocellular; CD4 Lymphocyte Count; Cyclosporine; Drug Substitution; End Stage Liver Disease; Female; Graft Rejection; Graft Survival; Hepatitis C, Chronic; HIV; HIV Infections; Hospitals, University; Humans; Immunosuppressive Agents; Italy; Kaplan-Meier Estimate; Liver Neoplasms; Liver Transplantation; Male; Middle Aged; Recurrence; RNA, Viral; Severity of Illness Index; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome; Viral Load | 2011 |
YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
Topics: Adipokines; Adult; Antiviral Agents; Chitinase-3-Like Protein 1; Cyclosporine; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Female; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lectins; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; Sex Factors; Statistics, Nonparametric; Tacrolimus; Time Factors; Young Adult | 2013 |